Blueshift Asset Management, LLC Insulet Corp Transaction History

Blueshift Asset Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$163.6 - $209.11 $490,800 - $627,330	3,000 New	3,000 $514,000
Q2 2023 Aug 15, 2023	BUY	$272.48 - $330.23 $341,689 - $414,108	1,254 New	1,254 $361,000
Q3 2022 Nov 14, 2022	BUY	$224.6 - $281.45 $332,857 - $417,108	1,482 Added 111.93%	2,806 $644,000
Q2 2022 Aug 12, 2022	SELL	$186.4 - $279.02 $305,696 - $457,592	-1,640 Reduced 55.33%	1,324 $289,000
Q1 2022 May 12, 2022	BUY	$194.8 - $275.7 $256,941 - $363,648	1,319 Added 80.18%	2,964 $790,000
Q4 2021 Feb 11, 2022	BUY	$255.32 - $318.29 $204,000 - $254,313	799 Added 94.44%	1,645 $438,000
Q3 2021 Nov 12, 2021	SELL	$260.36 - $307.27 $831,069 - $980,805	-3,192 Reduced 79.05%	846 $240,000
Q2 2021 Aug 13, 2021	BUY	$225.52 - $304.06 $910,649 - $1.23 Million	4,038 New	4,038 $1.11 Million

713

62.9M

640K

858K

Ticker PODD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 69,403,600
Market Cap $19.4B
Description
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...

Get notified when there are updates to the investment portfolio of Blueshift Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Blueshift Asset Management, LLC with notifications on news.